KIT | KIT-Bibliothek | Impressum

Innovation, pricing and regulatory policies in the German pharmaceutical market

Millas, Christoph de

Abstract (englisch): The legislator uses regulative instruments to induce a specific behavior in the drug market of the German Statutory Health Insurance. Empirical and theoretical models were used to evaluate them. Reference pricing, co-payments, lead compounds, and rebate contracts have an effect on prescription behavior. The latter however might lead to monopolies while the early benefit evaluation does not encourage investments into leap innovations. Overall, the instruments only partially fulfill their goal.

Zugehörige Institution(en) am KIT Institut für Volkswirtschaftslehre (ECON)
Publikationstyp Hochschulschrift
Jahr 2016
Sprache Englisch
Identifikator DOI(KIT): 10.5445/IR/1000055558
URN: urn:nbn:de:swb:90-555584
KITopen ID: 1000055558
Verlag Karlsruhe
Abschlussart Dissertation
Fakultät Fakultät für Wirtschaftswissenschaften (WIWI)
Institut Institut für Volkswirtschaftslehre (ECON)
Prüfungsdaten 30.05.2016
Referent/Betreuer Prof. K. Mitusch
Schlagworte Health care system, physicians, rebate contracts, early benefit evaluation, innovation
KIT – Die Forschungsuniversität in der Helmholtz-Gemeinschaft KITopen Landing Page